Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Nivolumab

Liver failure: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Grimm MO, et al. Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy: Interim Results from the Noninterventional NORA Study. European Urology Focus 8 : 1289-1299, No. 5, Sep 2022. Available from: URL: http://doi.org/10.1016/j.euf.2021.11.006 Grimm MO, et al. Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy: Interim Results from the Noninterventional NORA Study. European Urology Focus 8 : 1289-1299, No. 5, Sep 2022. Available from: URL: http://​doi.​org/​10.​1016/​j.​euf.​2021.​11.​006
Metadaten
Titel
Nivolumab
Liver failure: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41990-5

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Ciclosporin

Case report

Carbamazepine

Case report

Multiple drugs